IL7 and breast carcinoma: These observations have been followed by functional studies demonstrating mitogenic [28] and antiapoptotic activity [29] of IL-7 toward lung-cancer cells and its ability to induce VEGF-D expression and promote lymphangiogenesis in lung- [28] and breast-cancer [30] models.